weight loss drug trial

Tirzepatide, an injection medication already approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes, is likely to receive FDA approval for another indication — weight loss — later this year, according to multiple reports. The medication from Eli Lilly has the potential to become a “blockbuster” weight-loss drug, according to reports. Yet … Read more